Physician profile
Alan M Singer
NPI 1538221395
$2,076.29
in general payments reported to CMS, 2019-2025
27 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $412 · 2020: $89.84 · 2021: $304 · 2022: $498 · 2023: $487 · 2024: $115 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $773.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $423.72 | 2022-2025 | Kimyrsa |
| Smith+Nephew, INC. | $226.19 | 2019-2025 | Stravix, Grafix Pl |
| Dynasplint Systems INC. | $195.46 | 2021 | |
| Abbvie INC. | $172.46 | 2023 | Dalvance |
| Nevro Corp. | $148.36 | 2022 | |
| Horizon Therapeutics Plc | $146.88 | 2019 | |
| Kci USA, INC. | $116.70 | 2019-2023 | Activ.A.C. |
| Solventum Corporation | $72.98 | 2024 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Mimedx Group, INC. | $67.26 | 2025 | |
| Organogenesis INC. | $48.00 | 2023-2024 | Puraply Am, Puraply |
| Polynovo North America LLC | $47.96 | 2023 | |
| Depuy Synthes Sales INC. | $46.87 | 2025 | Na |
| Integra Lifesciences Corporation | $42.80 | 2019-2022 | |
| Polarityte, INC. | $38.96 | 2019 | |
| Paratek Pharmaceuticals, INC. | $38.64 | 2020-2023 | Nuzyra |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $33.55 | 2021 | |
| Next Science LLC | $32.45 | 2023 | Blastx, Xperience, Surgx |
| Zimmer Biomet Holdings, INC. | $31.78 | 2019 | |
| Bioventus LLC | $21.16 | 2021 | |
| Tei Medical INC. | $21.15 | 2019 | |
| Zyla Life Sciences, INC. | $16.92 | 2019 | |
| Medtronic, INC. | $15.63 | 2024 | Accurian |
| Celularity INC. | $15.00 | 2019 | |
| Tactile Systems Technology INC | $14.86 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.30 | 2019 | |
| Orthofix Medical, INC. | $13.94 | 2025 | Physio-Stim |
| Derma Sciences, INC. | $12.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Singer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.